Liposomes are now considered the most commonly used nanocarriers for various potentially
active hydrophobic and hydrophilic molecules due to their high biocompatibility …

Despite the exceptional progress in breast cancer pathogenesis, prognosis, diagnosis, and
treatment strategies, it remains a prominent cause of female mortality worldwide …

Doxorubicin (DOX) is a potent anti-cancer agent that has garnered great interest in research
due to its high efficacy despite dose-limiting toxicities. Several strategies have been …

Nano-oncology is a branch of biomedical research and engineering that focuses on using
nanotechnology in cancer diagnosis and treatment. Nanomaterials are extensively …

Simple Summary The advancement of nanotechnology over the last three decades has
given new hope to cancer management. The first FDA-approved nanomedicine (DOXIL) was …

The science of nanotechnology has been proposed as a factor of main change in the field of
cancer diagnosis and treatment. The challenges in common clinical treatment of breast …

Peptides can act as targeting molecules, analogously to oligonucleotide aptamers and
antibodies. They are particularly efficient in terms of production and stability in physiological …

Nanoparticles (NPs) have been used in numerous applications as anticancer, antibacterial
and antioxidant agents. Artificial engineering of protein interactions with NPs in biological …

Nano-drug delivery systems have opened new pathways for tumor treatment by overcoming
some of the limitations of conventional drugs, such as physiological degradation, short half …

In drug development, it is not uncommon that an active substance exhibits efficacy in vitro
but lacks the ability to specifically reach its target in vivo. As a result, targeted drug delivery …